Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity ; volume:13 ; number:1 ; day:30 ; month:11 ; year:2020 ; pages:1-19 ; date:12.2020
Journal of hematology & oncology ; 13, Heft 1 (30.11.2020), 1-19, 12.2020
- Urheber
-
Kuo, Tracy C.
Chen, Amy
Harrabi, Ons
Sockolosky, Jonathan T.
Zhang, Anli
Sangalang, Emma
Doyle, Laura V.
Kauder, Steven E.
Fontaine, Danielle
Bollini, Sangeetha
Han, Bora
Fu, Yang-Xin
Sim, Janet
Pons, Jaume
Wan, Hong I.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-020-00989-w
- URN
-
urn:nbn:de:101:1-2021010907110042250101
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kuo, Tracy C.
- Chen, Amy
- Harrabi, Ons
- Sockolosky, Jonathan T.
- Zhang, Anli
- Sangalang, Emma
- Doyle, Laura V.
- Kauder, Steven E.
- Fontaine, Danielle
- Bollini, Sangeetha
- Han, Bora
- Fu, Yang-Xin
- Sim, Janet
- Pons, Jaume
- Wan, Hong I.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia
DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity
Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses
Integrin CD11b activation drives anti-tumor innate immunity
Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade
Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis
Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity
Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer
Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia
DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity
Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses
Integrin CD11b activation drives anti-tumor innate immunity
Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade
Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis
Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity
Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer
Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia
DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity
Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses
Integrin CD11b activation drives anti-tumor innate immunity
Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade
Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis
Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity